Steroid Hormone Profiles and Molecular Diagnostic Tools in Pediatric Patients With non-CAH Primary Adrenal Insufficiency
Menevse, Tuba Seven, Demirkol, Yasemin Kendir, Tosun, Busra Gurpinar, Bayramoglu, Elvan, Yildiz, Melek, Acar, Sezer, Karaca, Seda Erisen, Orbak, Zerrin, Onder, Asan, Sobu, Elif, Anik, Ahmet, Atay, Zeynep, Bugrul, Fuat, Bulus, Ayse Derya, Demir, Korcan, Dogan, Durmus, Emeksiz, Hamdi Cihan, Kirmizibekmez, Heves, Murat, Nurhan Ozcan, Yaman, Akan, Turan, Serap, Bereket, Abdullah, Guran, Tulay
Context There is a significant challenge of attributing specific diagnoses to patients with primary adrenal insufficiency of unknown etiology other than congenital adrenal hyperplasia (non-CAH PAI). Specific diagnoses per se may guide personalized treatment or may illuminate pathophysiology. Objective This work aimed to investigate the efficacy of steroid hormone profiles and high-throughput sequencing methods in establishing the etiology in non-CAH PAI of unknown origin. Methods Pediatric patients with non-CAH PAI whose etiology could not be established by clinical and biochemical characteristics were enrolled. Genetic analysis was performed using targeted-gene panel sequencing (TPS) and whole-exome sequencing (WES). Plasma adrenal steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. This study comprised 18 pediatric endocrinology clinics with 41 patients (17 girls, median age: 3 mo, range: 0-8 y) with non-CAH PAI of unknown etiology. Results A genetic diagnosis was obtained in 29 (70.7%) patients by TPS. Further molecular diagnosis could not be achieved by WES. Compared to a healthy control group, patients showed lower steroid concentrations, most statistically significantly in cortisone, cortisol, and corticosterone (P < .0001, area under the receiver operating characteristic curve: .96, .88, and .87, respectively). Plasma cortisol of less than 4 ng/mL, cortisone of less than 11 ng/mL, and corticosterone of less than 0.11 ng/mL had a greater than 95% specificity to ensure the diagnosis of non-CAH PAI of unknown etiology. Conclusion Steroid hormone profiles are highly sensitive for the diagnosis of non-CAH PAI of unknown etiology, but they are unlikely to point to a specific molecular diagnosis. TPS is an optimal approach in the molecular diagnosis of these patients with high efficacy, whereas little additional benefit is expected from WES.
- Journal
- JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Year
- 2022
- Volume
- 107
- Issue
- 5
- Pages
- E1924-E1931
- ISSN
- 0021-972X
- eISSN
- 1945-7197
- DOI
- 10.1210/clinem/dgac016
- WoS UID
- WOS:000783663300043